Actively Recruiting
Manchester Procedure Versus Vaginal Hysterectomy for Women With Uterine Prolapse: A Multi-Center Randomized Controlled Study (The Fin-UP Trial)
Led by Tampere University Hospital · Updated on 2026-05-11
426
Participants Needed
6
Research Sites
417 weeks
Total Duration
On this page
Sponsors
T
Tampere University Hospital
Lead Sponsor
H
Helsinki University Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to compare two surgical treatments for women with symptomatic uterine prolapse, a condition where pelvic organs descend and affect quality of life. The trial evaluates the Manchester procedure, a uterus-preserving surgery, against vaginal hysterectomy, which removes the uterus and has been the standard treatment. The study focuses on success rates at two years post-operation and includes long-term follow-up to better understand patient outcomes. Participants are randomly assigned to either the Manchester procedure or vaginal hysterectomy group. The Manchester procedure involves modifying and suturing the cervix and surrounding ligaments while preserving the uterus, along with repairing other pelvic areas if needed. Vaginal hysterectomy involves removing the uterus through the vagina, suspending pelvic ligaments, and repairing additional pelvic defects as indicated. Both groups may receive further repairs such as anterior and posterior colporrhaphy and perineorrhaphy. Follow-up visits are scheduled at 2 and 5 years, with questionnaires completed at 1, 2, 5, and 10 years after surgery. During the study, participants will undergo clinical examinations, ultrasound assessments, and complete detailed questionnaires addressing pelvic symptoms, quality of life, sexual function, and satisfaction. Researchers will measure treatment success by the absence of prolapse beyond the hymen, lack of bulge symptoms, and no need for retreatment. Other outcomes include adverse events, surgery details like blood loss and operating time, and long-term complications. The study spans up to 10 years of follow-up, providing valuable data on the effectiveness and safety of both surgical options.
CONDITIONS
Brief Title
The Finnish Uterine Prolapse Surgery Trial (The Fin-UP Trial)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fit for elective vaginal surgery according to standard preoperative assessment
- Women aged over 18 years
- No previous pelvic organ prolapse surgery
- Symptomatic pelvic organ prolapse stage 2 or higher, with uterine descent of at least stage 2 (POP-Q point C 65 minus 1) and with POP-Q point D 64 minus 1
- Patients with concurrent anterior or posterior compartment defects are included
You will not qualify if you...
- Pregnancy or future plans of pregnancy
- Active malignancy of any kind
- Contraindications for uterine preservation such as suspected cervical or uterine malignancy, abnormal cervical cytology, abnormal uterine bleeding, history of endometrial hyperplasia with atypia, or known hereditary cancer syndrome involving the uterus
- Contraindication to vaginal hysterectomy, for example, extensive intra-abdominal adhesions
- Patient preference for uterine removal or preservation
- Planned concomitant incontinence procedure
- Inability to speak Finnish or Swedish, understand the study purpose, or commit to follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Days from operation to discharge
Participants undergo either the Manchester procedure or vaginal hysterectomy surgery to treat uterine prolapse. This stage includes surgery and immediate recovery care.
1 perioperative visit
Duration - Up to 2 months after surgery
Participants are followed up to monitor recovery, assess surgical outcomes, and evaluate pelvic floor symptoms, quality of life, and adverse events.
Visits at 1 and 2 months post-operation
Duration - Up to 10 years
Participants are monitored long-term to assess surgical success, symptom improvement, reoperation rates, and quality of life at multiple timepoints.
Visits at 1, 2, 5, and 10 years post-surgery
Trial Site Locations
Total: 6 locations
1
Helsinki University Hospital
Helsinki, Finland
Actively Recruiting
2
Hospital Nova, The Wellbeing Services County of Central Finland
Jyväskylä, Finland
Actively Recruiting
3
Kuopio University Hospital
Kuopio, Finland
Actively Recruiting
4
Oulu University Hospital
Oulu, Finland
Actively Recruiting
5
Tampere University Hospital
Tampere, Finland
Actively Recruiting
6
Turku University Hospital
Turku, Finland
Actively Recruiting
Research Team
P
Päivi K Karjalainen, MD, PhD
A
Anniina Karioja, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here